AngioDynamics rises on better-than-expected Q3 EPS
Shares of AngioDynamics (Nasdaq:ANGO) are advancing this morning after the medical devices provider reported third-quarter earnings after Wednesday’s close that substantially beat the consensus on Wall Street. Results were in part helped by a one time gain from a settlement with Diomed concerning a patent infringement. The company also issued 2008 revenue guidance above analysts’ average estimate.
Shares gained 12.55%, or$1.45, to $13 at 10:15 a.m. ET. For detailed price information and recent news stories about AngioDynamics, click ANGO.
